A Russian medical worker displays a trial vaccine against COVID-19 in a post-registration phase of the test at outpatient hospital number 68 in Moscow, Russia, 17 September 2020. Russia registered the new vaccine called 'Sputnik V' against Coronavirus Sars-Cov-2 and opens the stage of its massive testing. EPA-EFE/SERGEI ILNITSKY

The Torlak Institute has started the production of the Russian vaccine Sputnik V in Serbia, the Russian Fund for Direct Investments announced on its website. The Russian fund states that Serbia has become the first country in southern Europe to produce Sputnik V and that the production of the vaccine in Serbia meets the best standards. “Within the agreement reached between the Russian Fund for Direct Investments and the Torlak Institute, the production of the Sputnik V vaccine was successfully launched in Serbia in a short period of time. Serbia is the first European country to start producing a Russian vaccine,” said Russian fund director Kiril Dmitriev. . The vaccine, they added, could later be exported to other countries in the region. Vaccination against the coronavirus with the Russian vaccine began in Serbia on January 6, 2021, reminds the Russian Fund. Minister Nenad Popović also announced on his Twitter account that the first filling of vaccine doses has already been done. “Today, in the presence of experts from the Russian Direct Investment Fund, the Russian government and the Russian pharmaceutical company Generium, the first batch of control doses of the Sputnik V vaccine was filled at the Torlak Institute. Production will start on May 20,” the Serbian minister said on Twitter.